Whitehawk Therapeutics (WHWK) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, conducted virtually with agenda and rules posted online.

• Only validated stockholders could participate and ask questions via the meeting website.

• Notice of the meeting and proxy materials were distributed to all stockholders of record as of April 17, 2026.

Shareholder proposals

• Three proposals were presented: election of three Class 3 directors, advisory approval of executive compensation for 2025, and ratification of BDO USA, P.C. as auditor for 2026.

• Board recommended voting in favor of all proposals.

Overview of voting outcomes

• All three Class 3 director nominees were elected for terms expiring at the 2029 AGM.

• Advisory vote on executive compensation passed.

• Ratification of BDO USA, P.C. as independent auditor was approved.

• Final voting results to be filed on Form 8-K within four business days.